Dental Anxiety Alters Stress-Related mRNA Expression and Elevates Salivary Cortisol, Alpha-Amylase.
Background
Understanding the molecular underpinnings of dental anxiety (DA) is crucial, as it affects a significant portion of the population and often leads to avoidance of necessary dental care. Previous research has linked DA to activation of the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic-adrenal-medullary (SAM) system, evidenced by elevated salivary cortisol and alpha-amylase. However, the specific peripheral molecular mechanisms, particularly changes in gene expression related to stress response, remain largely unexplored. This study aimed to identify alterations in peripheral blood mRNA expression of key stress-related genes and their correlation with established salivary biomarkers in DA patients.
Study Design
This cross-sectional study investigated 30 DA patients and 28 non-DA patients. Researchers collected peripheral blood samples to determine mRNA expression levels of glucocorticoid receptor (GR), GR transcripts containing exons 1B (GR-1B), glutamate ionotropic receptor AMPA type subunit 1 (GRIA1), oxytocin (OT), oxytocin receptor (OTR), and Poly ADP-Ribose Polymerase 1 (PARP1). These levels were quantified using real-time quantitative polymerase chain reaction (qPCR). Additionally, salivary cortisol and alpha-amylase concentrations were measured using enzyme-linked immunosorbent assay (ELISA) to correlate molecular findings with established stress biomarkers.
Results
The study revealed significant differences in both peripheral blood mRNA expression and salivary biomarker levels between dental anxiety (DA) and non-DA groups. Specifically, GR-1B mRNA expression was significantly higher in the DA group compared to the non-DA group. Conversely, GRIA1 mRNA expression levels were significantly lower in the DA group, as were OT mRNA expression levels. These molecular changes were paralleled by alterations in established stress markers. Salivary cortisol levels were significantly higher in the DA group, indicating increased HPA axis activity. Concurrently, salivary alpha-amylase levels were also significantly higher in the DA group, reflecting heightened sympathetic-adrenal-medullary activation. No significant differences were reported for GR, OTR, or PARP1 mRNA expression in the abstract. These findings suggest a distinct molecular signature associated with dental anxiety.
GR-1BmRNA expression was significantly higher in the DA group, whileGRIA1andOTmRNA levels were significantly lower, alongside elevated salivary cortisol and alpha-amylase.
Key Findings
GR-1BmRNA expression was significantly higher in the DA group.GRIA1mRNA expression was significantly lower in the DA group.OTmRNA expression was significantly lower in the DA group.- Salivary cortisol levels were significantly higher in the DA group.
- Salivary alpha-amylase levels were significantly higher in the DA group.
Why It Matters
These findings provide crucial preliminary evidence for the biological correlates of dental anxiety, moving beyond purely psychological assessments. Identifying specific molecular markers like GR-1B, GRIA1, and OT mRNA, alongside salivary cortisol and alpha-amylase, could pave the way for developing non-invasive diagnostic biomarker panels. Such panels could objectively identify individuals at higher risk or suffering from DA, allowing for earlier intervention and personalized management strategies. This could significantly improve patient outcomes by reducing avoidance of dental care. While not immediately translatable to a specific protocol, this research highlights potential targets for future pharmacological or behavioral interventions aimed at modulating stress response pathways in anxious patients.
dental-anxiety
stress
biomarkers
hpa-axis
sam-axis
cortisol